Sabra Healthcare REIT (NASDAQ:SBRA) Hits New 12-Month High – Here’s Why

Sabra Healthcare REIT, Inc. (NASDAQ:SBRA)’s stock price reached a new 52-week high during trading on Tuesday . The stock traded as high as $21.52 and last traded at $21.5630, with a volume of 2164520 shares changing hands. The stock had previously closed at $20.00.

Sabra Healthcare REIT News Summary

Here are the key news stories impacting Sabra Healthcare REIT this week:

• Positive Sentiment: Truist Financial raised its price target on Sabra Healthcare REIT from $22 to $24 and reiterated a buy rating, signaling confidence in further upside. Benzinga
• Positive Sentiment: Citizens JMP lifted its price target from $23 to $25 and maintained a market outperform rating, suggesting analysts see additional room for the stock to climb. Benzinga
• Positive Sentiment: Sabra increased FY 2026 EPS guidance to $1.53-$1.55, above the consensus estimate of $1.50, which supports the case for stronger-than-expected earnings. Business Wire
• Positive Sentiment: The company announced a major portfolio reshaping, including plans to re-tenant properties previously leased to Avamere, which may improve occupancy stability and operational quality over time. TipRanks
• Neutral Sentiment: Zacks noted SBRA was a strong recent mover on heavy volume, but also warned that recent FFO estimate revisions could limit near-term follow-through. Zacks

Analyst Ratings Changes

Several research firms have issued reports on SBRA. Cantor Fitzgerald raised their price target on shares of Sabra Healthcare REIT from $21.00 to $22.00 and gave the stock a “neutral” rating in a research report on Monday, May 11th. Wells Fargo & Company increased their target price on shares of Sabra Healthcare REIT from $22.00 to $23.00 and gave the company an “overweight” rating in a research note on Monday, June 1st. Weiss Ratings downgraded Sabra Healthcare REIT from a “buy (b+)” rating to a “buy (b)” rating in a research report on Thursday, June 4th. Raymond James Financial assumed coverage on Sabra Healthcare REIT in a research note on Wednesday, June 17th. They set an “underperform” rating on the stock. Finally, Wall Street Zen raised Sabra Healthcare REIT from a “sell” rating to a “hold” rating in a report on Sunday, June 28th. Eight equities research analysts have rated the stock with a Buy rating, five have given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $22.25.

Sabra Healthcare REIT Stock Performance

The company has a quick ratio of 4.72, a current ratio of 4.72 and a debt-to-equity ratio of 0.96. The stock has a market capitalization of $5.54 billion, a price-to-earnings ratio of 34.89, a price-to-earnings-growth ratio of 1.64 and a beta of 0.65. The stock’s 50-day simple moving average is $19.63 and its 200 day simple moving average is $19.80.

Sabra Healthcare REIT (NASDAQ:SBRA) last posted its earnings results on Wednesday, April 29th. The real estate investment trust reported $0.16 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.16. The company had revenue of $211.74 million during the quarter, compared to analysts’ expectations of $209.20 million. Sabra Healthcare REIT had a net margin of 19.22% and a return on equity of 5.60%. Sabra Healthcare REIT’s quarterly revenue was up 20.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.37 earnings per share. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. Analysts expect that Sabra Healthcare REIT, Inc. will post 1.5 earnings per share for the current fiscal year.

Sabra Healthcare REIT Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, May 29th. Stockholders of record on Friday, May 15th were paid a $0.30 dividend. The ex-dividend date was Friday, May 15th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 5.5%. Sabra Healthcare REIT’s dividend payout ratio (DPR) is 190.48%.

Institutional Investors Weigh In On Sabra Healthcare REIT

A number of hedge funds have recently added to or reduced their stakes in SBRA. Vanguard Group Inc. raised its stake in shares of Sabra Healthcare REIT by 1.4% in the fourth quarter. Vanguard Group Inc. now owns 35,430,016 shares of the real estate investment trust’s stock worth $671,045,000 after acquiring an additional 481,231 shares during the last quarter. Principal Financial Group Inc. increased its holdings in shares of Sabra Healthcare REIT by 0.4% in the first quarter. Principal Financial Group Inc. now owns 25,052,121 shares of the real estate investment trust’s stock valued at $481,755,000 after purchasing an additional 98,770 shares in the last quarter. Nuveen LLC increased its holdings in shares of Sabra Healthcare REIT by 28.6% in the fourth quarter. Nuveen LLC now owns 7,303,254 shares of the real estate investment trust’s stock valued at $138,324,000 after purchasing an additional 1,625,072 shares in the last quarter. Geode Capital Management LLC raised its position in Sabra Healthcare REIT by 2.9% in the 4th quarter. Geode Capital Management LLC now owns 7,018,556 shares of the real estate investment trust’s stock worth $132,949,000 after purchasing an additional 198,118 shares during the last quarter. Finally, Bank of America Corp DE lifted its holdings in Sabra Healthcare REIT by 9.4% during the 3rd quarter. Bank of America Corp DE now owns 5,224,116 shares of the real estate investment trust’s stock worth $97,378,000 after buying an additional 447,528 shares in the last quarter. Institutional investors own 99.40% of the company’s stock.

About Sabra Healthcare REIT

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.